Cargando…

Evidence of SARS-CoV-2 re-infection with a different genotype

Detalles Bibliográficos
Autores principales:	Colson, Philippe, Finaud, Michael, Levy, Nicolas, Lagier, Jean-Christophe, Raoult, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of The British Infection Association. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666873/ https://www.ncbi.nlm.nih.gov/pubmed/33207255 http://dx.doi.org/10.1016/j.jinf.2020.11.011

Ejemplares similares

Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19
por: Colson, Philippe, et al.
Publicado: (2021)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
por: Dao, Thi Loi, et al.
Publicado: (2021)

Does spitting in public play a role in transmitting SARS-CoV-2?
por: Gautret, Philippe, et al.
Publicado: (2020)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Does SARS-CoV-2 re-infection depend on virus variant?
por: Gautret, Philippe, et al.
Publicado: (2021)

A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants
por: Colson, Philippe, et al.
Publicado: (2021)

Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020)

Screening for SARS-CoV-2 antibodies to save vaccine doses
por: Fenollar, Florence, et al.
Publicado: (2022)

Sequential Appearance and Isolation of a SARS-CoV-2 Recombinant between Two Major SARS-CoV-2 Variants in a Chronically Infected Immunocompromised Patient
por: Burel, Emilie, et al.
Publicado: (2022)

Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France
por: Colson, Philippe, et al.
Publicado: (2020)

Chloroquine for the 2019 novel coronavirus SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020)

The emergence, dynamics and significance of SARS-CoV-2 variants
por: COLSON, Philippe, et al.
Publicado: (2022)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Occurrence of a substitution or deletion of SARS-CoV-2 spike amino acid 677 in various lineages in Marseille, France
por: Colson, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant
por: Fournier, Pierre-Edouard, et al.
Publicado: (2021)

Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to advances statistical methods and designs for clinical trials for COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness
por: Devaux, Christian A., et al.
Publicado: (2021)

Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France
por: Colson, Philippe, et al.
Publicado: (2022)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France
por: Dao, Thi Loi, et al.
Publicado: (2021)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Global Discrepancies between Numbers of Available SARS-CoV-2 Genomes and Human Development Indexes at Country Scales
por: Colson, Philippe, et al.
Publicado: (2021)

Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage
por: Colson, Philippe, et al.
Publicado: (2021)

Long-term persistence of olfactory and gustatory disorders in COVID-19 patients
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2021)

Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France
por: Hoang, Van-Thuan, et al.
Publicado: (2021)

SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding
por: Dudouet, Pierre, et al.
Publicado: (2022)

A 21L/BA.2-21K/BA.1 “MixOmicron” SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis
por: Colson, Philippe, et al.
Publicado: (2022)

Marseillevirus in the Pharynx of a Patient with Neurologic Disorders
por: Aherfi, Sarah, et al.
Publicado: (2016)

Introduction of the SARS-CoV-2 Beta variant from Comoros into the Marseille geographical area
por: Hoang, Van Thuan, et al.
Publicado: (2022)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

First evaluation of hydroxychloroquine recommendations in treating SARS-CoV-2
por: Roussel, Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_661rt1tj9umtg5tea297e2125d